{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:21:46Z","timestamp":1790972506540,"version":"4.1.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6,1]]},"DOI":"10.1097\/qad.0b013e32832afefc","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T11:23:27Z","timestamp":1242905007000},"page":"1097-1107","source":"Crossref","is-referenced-by-count":73,"title":["Immune reconstitution inflammatory syndrome among HIV-infected South African infants initiating antiretroviral therapy"],"prefix":"10.1097","volume":"23","author":[{"given":"Kelly","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Coovadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy","family":"Meyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Chi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cordula","family":"Reitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Strehlau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayle","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine J","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210130","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/QAD.0b013e3282f4a607","article-title":"Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study","volume":"22","author":"Murdoch","year":"2008","journal-title":"AIDS"},{"key":"R2-7-20210130","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1097\/00126334-200412150-00007","article-title":"Incidence of immune reconstitution syndrome in HIV\/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India","volume":"37","author":"Kumarasamy","year":"2004","journal-title":"J Acquir Immune Defic Sydr"},{"key":"R3-7-20210130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1473-3099(05)70140-7","article-title":"Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals","volume":"5","author":"Lawn","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"R4-7-20210130","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/QAD.0b013e328011efac","article-title":"Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa","volume":"21","author":"Lawn","year":"2007","journal-title":"AIDS"},{"key":"R5-7-20210130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/jac\/dki444","article-title":"Immune reconstitution inflammatory syndrome: more answers, more questions","volume":"57","author":"Shelburne","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"R6-7-20210130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.inf.0000195618.55453.9a","article-title":"Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected Thai children","volume":"25","author":"Puthanakit","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R7-7-20210130","first-page":"417","article-title":"Tuberculosis during early antiretroviral-induced immune reconstitution in HIV-infected children","volume":"11","author":"Zampoli","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"R8-7-20210130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.aids.0000161769.06158.8a","article-title":"Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy","volume":"19","author":"Shelburne","year":"2005","journal-title":"AIDS"},{"key":"R9-7-20210130","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/01.aids.0000131375.21070.06","article-title":"Immune restoration disease after antiretroviral therapy","volume":"18","author":"French","year":"2004","journal-title":"AIDS"},{"key":"R10-7-20210130","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S1473-3099(06)70463-7","article-title":"Immunological recovery and antiretroviral therapy in HIV-1 infection","volume":"6","author":"Battegay","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"R11-7-20210130","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1468-1293.2005.00277.x","article-title":"The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy","volume":"6","author":"Jevtovic","year":"2005","journal-title":"HIV Med"},{"key":"R15-7-20210130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2471\/BLT.05.025189","article-title":"Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage","volume":"84","author":"Boerma","year":"2006","journal-title":"Bull World Health Organ"},{"key":"R16-7-20210130","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1086\/433177","article-title":"Immune reconstitution syndrome due to Bacillus Calmette-Gu\u00e9rin after initiation of antiretroviral therapy in children with HIV infection","volume":"41","author":"Puthanakit","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R17-7-20210130","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1086\/499953","article-title":"Bacille Calmette-Gu\u00e9rin (BCG) vaccine induced disease in HIV-infected and uninfected children","volume":"42","author":"Hesseling","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R18-7-20210130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vaccine.2006.07.020","article-title":"The risk of disseminated Bacille Calmette-Gu\u00e9rin (BCG) disease in HIV-infected children","volume":"25","author":"Hesseling","year":"2007","journal-title":"Vaccine"},{"key":"R21-7-20210130","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/QAI.0b013e3181642257","article-title":"Effect of rifampicin on lopinavir pharmacokinetics in HIV-infected children with tuberculosis","volume":"15","author":"Ren","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 1","key":"R22-7-20210130","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1086\/518659","article-title":"Diagnostic and management challenges for childhood tuberculosis in the era of HIV","volume":"196","author":"Marais","year":"2007","journal-title":"J Infect Dis"},{"key":"R24-7-20210130","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa0800971","article-title":"Early antiretroviral therapy and mortality among HIV-infected infants","volume":"359","author":"Violari","year":"2008","journal-title":"N Engl J Med"},{"key":"R27-7-20210130","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1086\/587900","article-title":"Long-term effects of long term antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting","volume":"46","author":"Patel","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R28-7-20210130","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1086\/430922","article-title":"Immune reconstitution after receipt of highly active antiretroviral therapy in children with advanced or progressive HIV disease and complete or partial viral load response","volume":"192","author":"Kovacs","year":"2005","journal-title":"J Infec Dis"},{"key":"R29-7-20210130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/QAD.0b013e3282f2be1d","article-title":"Pharmacokinetics, safety and efficacy of lopinavir\/ritonavir in infants less than 6 months of age: 24 week results","volume":"22","author":"Chadwick","year":"2008","journal-title":"AIDS"},{"key":"R30-7-20210130","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/QAD.0b013e32830437df","article-title":"Early virologic suppression with three-class antiretroviral therapy in HIV-infected African infants","volume":"22","author":"Prendergast","year":"2008","journal-title":"AIDS"},{"key":"R33-7-20210130","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/01.inf.0000177281.93658.df","article-title":"Ritonavir-based highly active antiretroviral therapy in human immunodeficiency virus type 1-infected infants younger than 24 months of age","volume":"24","author":"Chadwick","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R34-7-20210130","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(08)70182-8","article-title":"Paediatric tuberculosis","volume":"8","author":"Newton","year":"2008","journal-title":"Lancet"},{"key":"R35-7-20210130","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/jac\/dkl552","article-title":"Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis","volume":"59","author":"Ribera","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"R36-7-20210130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2431-8-34","article-title":"Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study","volume":"8","author":"Davies","year":"2008","journal-title":"BMC Pediatr"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-200906010-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:47:32Z","timestamp":1786038452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200906010-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,1]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32832afefc","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6,1]]}}}